Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

C. Tibaldi, E. Giovannetti, E. Vasile, V. Mey, A.C. Laan, S. Nannizzi, R. Di Marsico, A. Antonuzzo, C. Orlandini, S. Ricciardi, M. Del Tacca, G.J. Peters, A. Falcone, R. Danesi

Research output: Contribution to journalArticleAcademicpeer-review

190 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1797-1803
JournalClinical Cancer Research
Issue number6
Publication statusPublished - 2008

Cite this